VR therapeutic clinical trial data capture that joins headset use to patient outcomes

Virtual reality interventions are used in pain, anxiety, phobias, rehabilitation and cognitive training, and a trial is typically a randomized comparison of an immersive program against a sham, an active comparator or usual care. In published home-based chronic low back pain trials, for instance, the control was a sham VR experience on the same type of headset that was two-dimensional and non-immersive, intended to control for the novelty and hardware rather than the skills content. That design logic matters for data capture, because the sham arm also generates usage data that must look the same in structure as the active arm.

Exposure in a VR trial is software use. The headset or companion app records sessions started, minutes of use and modules completed; the study needs those numbers per participant, aligned with the outcome schedule. Capture does not integrate with headsets or product backends. A product team exports usage summaries, which the study team transcribes into a usage form or loads into the dataset in the analysis stage, matched on the coded participant ID. Define that interface in the data management plan and test it before enrollment. The data management plan template is a starting point.

This page is about the trial design side. If you are a digital therapeutics company deciding how to build a clinical evidence programme, see clinical validation software for digital therapeutics. For broader digital designs, EDC for digital health clinical trials and EDC for mobile health studies apply.

Most VR therapeutic trials are won or lost on patient-reported outcomes: pain intensity and interference, mood, anxiety, sleep or function. Participants answer on their phone from a secure link in the browser, with reminders and completion windows you set, which suits a home-based program. See how to capture patient-reported outcomes digitally and BYOD ePRO with no app download. Template pages for the structure of common measures include the numeric pain rating scale, brief pain inventory and GAD-7. They show structure and scoring only, and you remain responsible for licences.

VR brings its own tolerability profile. Dizziness, nausea and disorientation, often grouped under cybersickness or simulator sickness, and eye strain or headache, are regular concerns, and there are questionnaires developed to rate them. Record them with a short check after sessions, plus the standard adverse event form for events that meet the protocol threshold. A fall at home while wearing a headset is a different severity than a mild headache, and the protocol should define the safety rules. Because cybersickness may unblind a participant who knows their sham has no motion, the participant blinding question at the end of the study is worth collecting.

A VR trial that is a regulated software or device study also needs the right documentation. See FDA digital health technologies guidance for clinical trials for the guidance on using digital health technologies to collect data, and digital biomarker validation study software if headset-derived measures are being validated.